Align Technology (ALGN) Projected to Post Quarterly Earnings on Wednesday

Align Technology (NASDAQ:ALGN) is projected to release its earnings data after the market closes on Wednesday, January 29th. Analysts expect Align Technology to post earnings of $2.45 per share and revenue of $999,370.00 billion for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Align Technology (NASDAQ:ALGN) last issued its earnings results on Wednesday, October 23rd. The medical equipment provider reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.04. Align Technology had a net margin of 11.15% and a return on equity of 13.99%. The business had revenue of $977.87 million during the quarter, compared to analysts’ expectations of $990.05 million. During the same quarter in the prior year, the business posted $1.62 EPS. The company’s revenue for the quarter was up 1.8% on a year-over-year basis. On average, analysts expect Align Technology to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Align Technology Price Performance

Shares of NASDAQ:ALGN opened at $228.00 on Wednesday. Align Technology has a 12 month low of $196.09 and a 12 month high of $335.40. The firm has a market capitalization of $17.02 billion, a P/E ratio of 38.91, a P/E/G ratio of 4.91 and a beta of 1.67. The company’s fifty day moving average price is $222.09 and its 200 day moving average price is $227.95.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Mizuho assumed coverage on shares of Align Technology in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $295.00 price objective on the stock. Evercore ISI dropped their price target on shares of Align Technology from $270.00 to $250.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Robert W. Baird reduced their price objective on shares of Align Technology from $325.00 to $276.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Morgan Stanley dropped their target price on Align Technology from $310.00 to $280.00 and set an “overweight” rating on the stock in a research report on Thursday, October 24th. Finally, Bank of America raised their price target on Align Technology from $200.00 to $206.00 and gave the company an “underperform” rating in a report on Friday, December 13th. Two research analysts have rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $268.20.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.